Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Nanotherapeutics for multiple myeloma.

Zheleznyak A, Shokeen M, Achilefu S.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Nov;10(6):e1526. doi: 10.1002/wnan.1526. Epub 2018 Apr 26. Review.

PMID:
29701006
2.

Imaging Melphalan Therapy Response in Preclinical Extramedullary Multiple Myeloma with 18F-FDOPA and 18F-FDG PET.

Hathi DK, DeLassus EN, Achilefu S, McConathy J, Shokeen M.

J Nucl Med. 2018 Oct;59(10):1551-1557. doi: 10.2967/jnumed.118.208744. Epub 2018 Apr 26.

PMID:
29700126
3.

Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer.

Kotagiri N, Cooper ML, Rettig M, Egbulefu C, Prior J, Cui G, Karmakar P, Zhou M, Yang X, Sudlow G, Marsala L, Chanswangphuwana C, Lu L, Habimana-Griffin L, Shokeen M, Xu X, Weilbaecher K, Tomasson M, Lanza G, DiPersio JF, Achilefu S.

Nat Commun. 2018 Jan 18;9(1):275. doi: 10.1038/s41467-017-02758-9.

4.

Preclinical Development of CD38-Targeted [89Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma.

Ghai A, Maji D, Cho N, Chanswangphuwana C, Rettig M, Shen D, DiPersio J, Akers W, Dehdashti F, Achilefu S, Vij R, Shokeen M.

J Nucl Med. 2018 Feb;59(2):216-222. doi: 10.2967/jnumed.117.196063. Epub 2017 Oct 12.

5.

Enhancing in vivo tumor boundary delineation with structured illumination fluorescence molecular imaging and spatial gradient mapping.

Sun J, Miller JP, Hathi D, Zhou H, Achilefu S, Shokeen M, Akers WJ.

J Biomed Opt. 2016 Aug 1;21(8):80502. doi: 10.1117/1.JBO.21.8.080502.

6.

Evaluating Acetate Metabolism for Imaging and Targeting in Multiple Myeloma.

Fontana F, Ge X, Su X, Hathi D, Xiang J, Cenci S, Civitelli R, Shoghi KI, Akers WJ, D'avignon A, Weilbaecher KN, Shokeen M.

Clin Cancer Res. 2017 Jan 15;23(2):416-429. doi: 10.1158/1078-0432.CCR-15-2134. Epub 2016 Aug 2.

7.

Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents.

Soodgupta D, Zhou H, Beaino W, Lu L, Rettig M, Snee M, Skeath J, DiPersio JF, Akers WJ, Laforest R, Anderson CJ, Tomasson MH, Shokeen M.

J Nucl Med. 2016 Apr;57(4):640-5. doi: 10.2967/jnumed.115.164624. Epub 2016 Jan 7.

8.

New Approaches to Molecular Imaging of Multiple Myeloma.

Vij R, Fowler KJ, Shokeen M.

J Nucl Med. 2016 Jan;57(1):1-4. doi: 10.2967/jnumed.115.163808. Epub 2015 Nov 5. Review.

9.

Utilizing the Multiradionuclide Resolving Power of SPECT and Dual Radiolabeled Single Molecules to Assess Treatment Response of Tumors.

Xu B, Shokeen M, Sudlow GP, Harpstrite SE, Liang K, Cheney PP, Edwards WB, Sharma V, Laforest R, Akers WJ, Achilefu S.

Mol Imaging Biol. 2015 Oct;17(5):671-9. doi: 10.1007/s11307-015-0842-8.

10.

Noninvasive imaging of focal atherosclerotic lesions using fluorescence molecular tomography.

Maji D, Solomon M, Nguyen A, Pierce RA, Woodard PK, Akers WJ, Achilefu S, Culver JP, Abendschein DR, Shokeen M.

J Biomed Opt. 2014;19(11):110501. doi: 10.1117/1.JBO.19.11.110501.

11.

Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma.

Soodgupta D, Hurchla MA, Jiang M, Zheleznyak A, Weilbaecher KN, Anderson CJ, Tomasson MH, Shokeen M.

PLoS One. 2013;8(2):e55841. doi: 10.1371/journal.pone.0055841. Epub 2013 Feb 8. Erratum in: PLoS One. 2013;8(8). doi:10.1371/annotation/8532e291-73d3-461c-810d-0533ccb1eba0.

12.

Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors.

Jiang M, Ferdani R, Shokeen M, Anderson CJ.

Nucl Med Biol. 2013 Feb;40(2):245-51. doi: 10.1016/j.nucmedbio.2012.10.010. Epub 2012 Dec 23.

13.

Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche.

Shokeen M, Zheleznyak A, Wilson JM, Jiang M, Liu R, Ferdani R, Lam KS, Schwarz JK, Anderson CJ.

J Nucl Med. 2012 May;53(5):779-86. doi: 10.2967/jnumed.111.100073. Epub 2012 Apr 10.

14.

The development of copper radiopharmaceuticals for imaging and therapy.

Shokeen M, Wadas TJ.

Med Chem. 2011 Sep;7(5):413-29. Review.

PMID:
21711219
15.

Evaluation of multivalent, functional polymeric nanoparticles for imaging applications.

Shokeen M, Pressly ED, Hagooly A, Zheleznyak A, Ramos N, Fiamengo AL, Welch MJ, Hawker CJ, Anderson CJ.

ACS Nano. 2011 Feb 22;5(2):738-47. doi: 10.1021/nn102278w. Epub 2011 Jan 28.

16.

Design of targeted cardiovascular molecular imaging probes.

Anderson CJ, Bulte JW, Chen K, Chen X, Khaw BA, Shokeen M, Wooley KL, VanBrocklin HF.

J Nucl Med. 2010 May 1;51 Suppl 1:3S-17S. doi: 10.2967/jnumed.109.068130. Epub 2010 Apr 15. Review.

17.

Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).

Shokeen M, Anderson CJ.

Acc Chem Res. 2009 Jul 21;42(7):832-41. doi: 10.1021/ar800255q.

18.

Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis.

Almutairi A, Rossin R, Shokeen M, Hagooly A, Ananth A, Capoccia B, Guillaudeu S, Abendschein D, Anderson CJ, Welch MJ, Fréchet JM.

Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):685-90. doi: 10.1073/pnas.0811757106. Epub 2009 Jan 7.

Supplemental Content

Loading ...
Support Center